http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2167404-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-155 |
filingDate | 1984-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1786f9a2015f5140056f588c1dd800 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8387db777e09b23c37d47be16d765dd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4488efe73e3f9775e1d88a253b57c5fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ae061ab3f7cd8ad11023fb614b4fa07 |
publicationDate | 1986-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-2167404-A |
titleOfInvention | Prostanoid aminocyclopentane alkenoic acids and esters, their preparation and pharmaceutical formulation |
abstract | Pharmaceutical compositions in which the active ingredient has the formula <IMAGE> (in which R1 is H or various organic radicals; R2 is cinnamyl or is substituted or unsubstituted phenylalkyl, thienylalkyl or naphthylalkyl; R3 is -H, alkyl (optionally interrupted by -O- or -S-), alkanoyl, benzoyl, alkoxy- or benzyloxycarbonyl, or carbamyl or N-substituted carbamyl; Y is a 5-8 ring membered saturated heterocyclic amino group attached to the cyclopentane ring via N; X is -CH=CH-; and W is C1-7 alkylene> or is a salt or solvate thereof may be used as antithrombotic or antiasthmatic agents. Certain of the compounds (e.g. where R3 is other than -H) are new. |
priorityDate | 1984-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.